Hindustan Unilever Limited v. Ahuvan Industries

Merck Sharp & Dohme CorpvsSanjeev Gupta

The commercial suit for patent infringement concerning Sitagliptin (protected by IN 209816) was settled between Merck Sharp & Dohme Corp and Sanjeev Gupta & Ors. The Defendants acknowledged the validity of the patent and agreed to cease all infringing activities, including manufacturing generic versions, until the patent expires.

Fdc LimitedvsHealing Pharma India Private Limited

Fdc Limited filed a suit against Healing Pharma India Private Limited alleging multiple infringements related to its pharmaceutical products. The Delhi High Court issued an order addressing procedural aspects, including granting exemptions from pre-institution mediation and allowing the filing of additional documents. Crucially, the court also addressed interim relief, restraining the defendant from manufacturing or marketing products confusingly similar to Fdc's registered trademarks (ZIFI) and copyrighted trade dress (ELECTRAL).

Tibra CollectionvsFashnear Technologies Private Limited & Ors.

Tibra Collection filed suit against several unauthorized sellers operating on the Meesho platform (run by Fashnear Technologies Private Limited) for copyright infringement and passing off. The Plaintiff alleged that Defendants were selling counterfeit garments that copied their designs and misusing their copyrighted photographs. After initial interim injunctions, the parties reached a settlement agreement. The court subsequently decreed the suit against the infringing sellers (Defendants 2-6), formalizing the undertaking which included a payment of Rs. 10 lakh to Tibra Collection and permanent cessation of all infringing activities.

Interdigital Technology Corporation & Ors.vsGuangdong Oppo Mobile Telecommunications Corp. Ltd. & Ors.

Samsung Electronics filed applications seeking intervention to prevent the disclosure of its Patent License Agreement (PLA) dated 1st June, 2014, between Samsung and InterDigital Group Companies. The dispute centered on whether the PLA could be shared with defendants' in-house representatives within a confidentiality club established by the court. The Court ultimately directed that the PLA must be shown to the defendants' representatives, subject to specific restrictions.

Corcept Therapeutics IncorporatedvsThe Deputy Controller Of Patents And Designs

Corcept Therapeutics Incorporated filed an appeal against the Assistant Controller's order refusing to grant a patent for Indian Patent Application No. 202117031510. The appellant contends that the refusal was erroneous as the application meets all criteria for patentability, while the respondent argued it failed tests under Sections 2(1)(j), 2(1)(ja), and 3(e)/3(i) of the Patents Act.